Skip to main content
Chloe Atreya, MD, Oncology, San Francisco, CA, UCSF Medical Center

ChloeEAtreyaMD

Oncology San Francisco, CA

Instructor, Medicine, UCSF School of Medicine

Dr. Atreya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Atreya's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2008 - 2010
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 2005 - 2008
  • Yale School of Medicine
    Yale School of MedicineClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Diet Quality with Survival Among People with Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial  
    Kimmie Ng, Chloe Atreya, Howard S Hochster, James N Atkins, Richard M Goldberg, Charles D Blanke, Jeffrey A Meyerhardt, JAMA Network Open

Lectures

  • Molecular characterization of a gastric cancer transmitted from an organ donor to four transplant recipients. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020

Press Mentions

  • OncLive® Hosts State of the Science Summit™: Gastrointestinal Malignancies
    OncLive® Hosts State of the Science Summit™: Gastrointestinal MalignanciesFebruary 22nd, 2018
  • New ‘Immunoprofiler’ Initiative Will Advance Drug Discovery, Precision Immunotherapy for Cancer
    New ‘Immunoprofiler’ Initiative Will Advance Drug Discovery, Precision Immunotherapy for CancerJanuary 19th, 2017
  • Triplet Therapy Effective in BRAF-Mutant mCRC
    Triplet Therapy Effective in BRAF-Mutant mCRCJune 8th, 2015

Hospital Affiliations